Pharmaceutical Contract Development and Manufacturing Market 2028 By Service, End User and Geography | The Insight Partners

Pharmaceutical Contract Development and Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Service (Drug Development Services, Biologics Manufacturing Services, Pharmaceutical Manufacturing Services); End User (Generic Pharmaceutical Companies, Small and Mid-Size Pharmaceutical Companies, Big Pharmaceutical Companies) and Geography

Report Code: TIPRE00006706 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming

MARKET OVERVIEW

The process of developing drugs or APIs is referred to as pharmaceutical contract development and manufacturing services. With rising R&D and manufacturing costs, contract development and manufacturing of pharmaceutical products has become more popular. The contract development and manufacturing company serves drug development and manufacturing services for other pharmaceutical companies on a contract basis. The increasing trend of contract manufacturing among drug companies along with increasing number of pharmaceutical companies are expected to propel market growth during the forecast period.

MARKET SCOPE

The Global Pharmaceutical Contract Development and Manufacturing Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the pharmaceutical contract development and manufacturing market with detailed market segmentation by service and end user. The report provides key statistics on the market status of the leading pharmaceutical contract development and manufacturing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on service the market is segmented as, drug development services, biologics manufacturing services, and pharmaceutical manufacturing services.
  •   Based on end user the market is segmented as, generic pharmaceutical companies, small & mid-size pharmaceutical companies and big pharmaceutical companies.

MARKET DYNAMICS
Drivers:

  •   Increasing trend of contract manufacturing among drug companies.
  •   Increasing number of pharmaceutical companies.
  •   Patent expiration of existing drugs and growing demand for generic medicines is also expected to spur the market growth during the forecast period.
  •   Growing R&D expenditures by drug companies.

Restraints:

  •   However, presence of stringent regulatory framework is expected to restrain market growth during the forecast period.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The pharmaceutical contract development and manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the pharmaceutical contract development and manufacturing market in these regions.

IMPACT OF COVID-19 ON PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the pharmaceutical contract development and manufacturing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from pharmaceutical contract development and manufacturing market are anticipated to lucrative growth opportunities in the future with the rising demand for pharmaceutical contract development and manufacturing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the pharmaceutical contract development and manufacturing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   AbbVie Inc.
  •   Almac Group
  •   Catalent, Inc.
  •   Evonik
  •   Lonza
  •   Recipharm AB (publ)
  •   Siegfried Holding AG
  •   Aenova Group GmbH
  •   Vetter Pharma International GmbH
  •   Samsung Biologics
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmaceutical Contract Development And Manufacturing Market - By Service
1.3.2 Pharmaceutical Contract Development And Manufacturing Market - By End User
1.3.3 Pharmaceutical Contract Development And Manufacturing Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING - GLOBAL MARKET OVERVIEW
6.2. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE
7.1. OVERVIEW
7.2. SERVICE MARKET FORECASTS AND ANALYSIS
7.3. DRUG DEVELOPMENT SERVICES
7.3.1. Overview
7.3.2. Drug Development Services Market Forecast and Analysis
7.4. BIOLOGICS MANUFACTURING SERVICES
7.4.1. Overview
7.4.2. Biologics Manufacturing Services Market Forecast and Analysis
7.4.3. Biologics FDF Manufacturing Services Market
7.4.3.1. Overview
7.4.3.2. Biologics FDF Manufacturing Services Market Forecast and Analysis
7.4.4. Biologics Api Manufacturing Services Market
7.4.4.1. Overview
7.4.4.2. Biologics Api Manufacturing Services Market Forecast and Analysis
7.5. PHARMACEUTICAL MANUFACTURING SERVICES
7.5.1. Overview
7.5.2. Pharmaceutical Manufacturing Services Market Forecast and Analysis
7.5.3. Pharmaceutical API Manufacturing Services Market
7.5.3.1. Overview
7.5.3.2. Pharmaceutical API Manufacturing Services Market Forecast and Analysis
7.5.4. Pharmaceutical FDF Manufacturing Services Market
7.5.4.1. Overview
7.5.4.2. Pharmaceutical FDF Manufacturing Services Market Forecast and Analysis
8. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. GENERIC PHARMACEUTICAL COMPANIES
8.3.1. Overview
8.3.2. Generic Pharmaceutical Companies Market Forecast and Analysis
8.4. SMALL AND MID-SIZE PHARMACEUTICAL COMPANIES
8.4.1. Overview
8.4.2. Small and Mid-Size Pharmaceutical Companies Market Forecast and Analysis
8.5. BIG PHARMACEUTICAL COMPANIES
8.5.1. Overview
8.5.2. Big Pharmaceutical Companies Market Forecast and Analysis

9. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pharmaceutical Contract Development And Manufacturing Market Overview
9.1.2 North America Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis
9.1.3 North America Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Service
9.1.4 North America Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By End User
9.1.5 North America Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pharmaceutical Contract Development And Manufacturing Market
9.1.5.1.1 United States Pharmaceutical Contract Development And Manufacturing Market by Service
9.1.5.1.2 United States Pharmaceutical Contract Development And Manufacturing Market by End User
9.1.5.2 Canada Pharmaceutical Contract Development And Manufacturing Market
9.1.5.2.1 Canada Pharmaceutical Contract Development And Manufacturing Market by Service
9.1.5.2.2 Canada Pharmaceutical Contract Development And Manufacturing Market by End User
9.1.5.3 Mexico Pharmaceutical Contract Development And Manufacturing Market
9.1.5.3.1 Mexico Pharmaceutical Contract Development And Manufacturing Market by Service
9.1.5.3.2 Mexico Pharmaceutical Contract Development And Manufacturing Market by End User
9.2. EUROPE
9.2.1 Europe Pharmaceutical Contract Development And Manufacturing Market Overview
9.2.2 Europe Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis
9.2.3 Europe Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Service
9.2.4 Europe Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By End User
9.2.5 Europe Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pharmaceutical Contract Development And Manufacturing Market
9.2.5.1.1 Germany Pharmaceutical Contract Development And Manufacturing Market by Service
9.2.5.1.2 Germany Pharmaceutical Contract Development And Manufacturing Market by End User
9.2.5.2 France Pharmaceutical Contract Development And Manufacturing Market
9.2.5.2.1 France Pharmaceutical Contract Development And Manufacturing Market by Service
9.2.5.2.2 France Pharmaceutical Contract Development And Manufacturing Market by End User
9.2.5.3 Italy Pharmaceutical Contract Development And Manufacturing Market
9.2.5.3.1 Italy Pharmaceutical Contract Development And Manufacturing Market by Service
9.2.5.3.2 Italy Pharmaceutical Contract Development And Manufacturing Market by End User
9.2.5.4 Spain Pharmaceutical Contract Development And Manufacturing Market
9.2.5.4.1 Spain Pharmaceutical Contract Development And Manufacturing Market by Service
9.2.5.4.2 Spain Pharmaceutical Contract Development And Manufacturing Market by End User
9.2.5.5 United Kingdom Pharmaceutical Contract Development And Manufacturing Market
9.2.5.5.1 United Kingdom Pharmaceutical Contract Development And Manufacturing Market by Service
9.2.5.5.2 United Kingdom Pharmaceutical Contract Development And Manufacturing Market by End User
9.2.5.6 Rest of Europe Pharmaceutical Contract Development And Manufacturing Market
9.2.5.6.1 Rest of Europe Pharmaceutical Contract Development And Manufacturing Market by Service
9.2.5.6.2 Rest of Europe Pharmaceutical Contract Development And Manufacturing Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Overview
9.3.2 Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis
9.3.3 Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Service
9.3.4 Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pharmaceutical Contract Development And Manufacturing Market
9.3.5.1.1 Australia Pharmaceutical Contract Development And Manufacturing Market by Service
9.3.5.1.2 Australia Pharmaceutical Contract Development And Manufacturing Market by End User
9.3.5.2 China Pharmaceutical Contract Development And Manufacturing Market
9.3.5.2.1 China Pharmaceutical Contract Development And Manufacturing Market by Service
9.3.5.2.2 China Pharmaceutical Contract Development And Manufacturing Market by End User
9.3.5.3 India Pharmaceutical Contract Development And Manufacturing Market
9.3.5.3.1 India Pharmaceutical Contract Development And Manufacturing Market by Service
9.3.5.3.2 India Pharmaceutical Contract Development And Manufacturing Market by End User
9.3.5.4 Japan Pharmaceutical Contract Development And Manufacturing Market
9.3.5.4.1 Japan Pharmaceutical Contract Development And Manufacturing Market by Service
9.3.5.4.2 Japan Pharmaceutical Contract Development And Manufacturing Market by End User
9.3.5.5 South Korea Pharmaceutical Contract Development And Manufacturing Market
9.3.5.5.1 South Korea Pharmaceutical Contract Development And Manufacturing Market by Service
9.3.5.5.2 South Korea Pharmaceutical Contract Development And Manufacturing Market by End User
9.3.5.6 Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market
9.3.5.6.1 Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market by Service
9.3.5.6.2 Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Overview
9.4.2 Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis
9.4.3 Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Service
9.4.4 Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pharmaceutical Contract Development And Manufacturing Market
9.4.5.1.1 South Africa Pharmaceutical Contract Development And Manufacturing Market by Service
9.4.5.1.2 South Africa Pharmaceutical Contract Development And Manufacturing Market by End User
9.4.5.2 Saudi Arabia Pharmaceutical Contract Development And Manufacturing Market
9.4.5.2.1 Saudi Arabia Pharmaceutical Contract Development And Manufacturing Market by Service
9.4.5.2.2 Saudi Arabia Pharmaceutical Contract Development And Manufacturing Market by End User
9.4.5.3 U.A.E Pharmaceutical Contract Development And Manufacturing Market
9.4.5.3.1 U.A.E Pharmaceutical Contract Development And Manufacturing Market by Service
9.4.5.3.2 U.A.E Pharmaceutical Contract Development And Manufacturing Market by End User
9.4.5.4 Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market
9.4.5.4.1 Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market by Service
9.4.5.4.2 Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pharmaceutical Contract Development And Manufacturing Market Overview
9.5.2 South and Central America Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis
9.5.3 South and Central America Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Service
9.5.4 South and Central America Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By End User
9.5.5 South and Central America Pharmaceutical Contract Development And Manufacturing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pharmaceutical Contract Development And Manufacturing Market
9.5.5.1.1 Brazil Pharmaceutical Contract Development And Manufacturing Market by Service
9.5.5.1.2 Brazil Pharmaceutical Contract Development And Manufacturing Market by End User
9.5.5.2 Argentina Pharmaceutical Contract Development And Manufacturing Market
9.5.5.2.1 Argentina Pharmaceutical Contract Development And Manufacturing Market by Service
9.5.5.2.2 Argentina Pharmaceutical Contract Development And Manufacturing Market by End User
9.5.5.3 Rest of South and Central America Pharmaceutical Contract Development And Manufacturing Market
9.5.5.3.1 Rest of South and Central America Pharmaceutical Contract Development And Manufacturing Market by Service
9.5.5.3.2 Rest of South and Central America Pharmaceutical Contract Development And Manufacturing Market by End User

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, KEY COMPANY PROFILES
11.1. ABBVIE INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALMAC GROUP
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CATALENT, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. EVONIK
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LONZA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. RECIPHARM AB (PUBL)
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SIEGFRIED HOLDING AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. AENOVA GROUP GMBH
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. VETTER PHARMA INTERNATIONAL GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SAMSUNG BIOLOGICS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Almac Group
3. Catalent, Inc.
4. Evonik
5. Lonza
6. Recipharm AB (publ)
7. Siegfried Holding AG
8. Aenova Group GmbH
9. Vetter Pharma International GmbH
10. Samsung Biologics
11. Boehringer Ingelheim International GmbH
12. Cambrex Corporation
13. CordenPharma International
14. FUJIFILM Corporation
15. Piramal Pharma Solutions
TIPRE00006706
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount